Designing specific cheese-ripening ecosystems to shape the immune effects of dairy products?

Journal of Functional Foods

Volumn 12, Issue , 2015, Pages 219-229

  Plé, Coline ^a   Adouard, Nadège ^b   Breton, JérÔme ^a   Dewulf, Joëlle ^a   Pot, Bruno ^a   Bonnarme, Pascal ^b   Foligné, Benoit ^a  

^a UNIV LILLE   (France)

^b Université Paris Saclay   (France)

Author keywords

Colitis; Immunomodulation; Mouse model; PBMC; Smear cheese microflora

Indexed keywords

BACTERIA (MICROORGANISMS); MUS;

EID: 84920720080     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.11.021     Document Type: Article

References (61)

1. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., Ito E., Suzuki I., Kulkarni A.D., Kawajiri A., Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
2. Araujo R., Rodrigues A.G., Pina-Vaz C. A fast, practical and reproducible procedure for the standardization of the cell density of an Aspergillus suspension. Journal of Medical Microbiology 2004, 53:783-786.
3. Ashraf R., Vasiljevic T., Day S.L., Smith S.C., Donkor O.N. Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. Journal of Functional Foods 2014, 6:395-409.
4. Aune D., Lau R., Chan D.S., Vieira R., Greenwood D.C., Kampman E., Norat T. Dairy products and colorectal cancer risk: A systematic review and meta-analysis of cohort studies. Annals of Oncology 2012, 23:37-45.
5. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. New England Journal of Medicine 2002, 347:911-920.
6. Beermann C., Hartung J. Physiological properties of milk ingredients released by fermentation. Food & Function 2013, 4:185-199.
7. Birrenbach T., Bocker U. Inflammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inflammatory Bowel Diseases 2004, 10:848-859.
8. Blondiaux N., Gaillot O., Courcol R.J. MALDI-TOF mass spectrometry to identify clinical bacterial isolates: Evaluation in a teaching hospital in Lille. Pathologie-Biologie 2010, 58:55-57.
9. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. The Journal of Investigative Dermatology 1982, 78:206-209.
10. Chapman C.M., Gibson G.R., Rowland I. Health benefits of probiotics: Are mixtures more effective than single strains?. European Journal of Nutrition 2011, 50:1-17.
11. Claes I.J., De Keersmaecker S.C., Vanderleyden J., Lebeer S. Lessons from probiotic-host interaction studies in murine models of experimental colitis. Molecular Nutrition and Food Research 2011, 55:1441-1453.
12. Clarke J.O., Mullin G.E. A review of complementary and alternative approaches to immunomodulation. Nutrition in Clinical Practice 2008, 23:49-62.
13. Colombel J.F., Watson A.J., Neurath M.F. The 10 remaining mysteries of inflammatory bowel disease. Gut 2008, 57:429-433.
14. Cosnes J. Tobacco and IBD: Relevance in the understanding of disease mechanisms and clinical practice. Best Practice & Research. Clinical Gastroenterology 2004, 18:481-496.
15. David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., Biddinger S.B., Dutton R.J., Turnbaugh P.J. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
16. Drouault-Holowacz S., Foligné B., Dennin V., Goudercourt D., Terpend K., Burckel A., Pot B. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: In vitro and in vivo considerations. Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition 2006, 25:994-1003.
17. Foligné B., Daniel C., Pot B. Probiotics from research to market: The possibilities, risks and challenges. Current Opinion in Microbiology 2013, 16:284-292.
18. Foligné B., Dewulf J., Vandekerckove P., Pignède G., Pot B. Probiotic yeasts: Anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World Journal of Gastroenterology 2010, 16:2134-2145.
19. Foligne B., Dessein R., Marceau M., Poiret S., Chamaillard M., Pot B., Simonet M., Daniel C. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 2007, 133:862-874.
20. Foligne B., Nutten S., Grangette C., Dennin V., Goudercourt D., Poiret S., Dewulf J., Brassart D., Mercenier A., Pot B. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology 2007, 13:236-243.
21. Gentschew L., Ferguson L.R. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Molecular Nutrition and Food Research 2012, 56:524-535.
22. Gionchetti P., Calafiore A., Pratico C., Laureti S., Vitali G., Poggioli G., Campieri M., Rizzello F. Randomized controlled trials in pouchitis. Reviews on Recent Clinical Trials 2012, 7:303-306.
23. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., Campieri M., Kamm M.A., Knight S.C., Stagg A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
24. Hartmann G., Bidlingmaier C., Siegmund B., Albrich S., Schulze J., Tschoep K., Eigler A., Lehr H.A., Endres S. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. The Journal of Pharmacology and Experimental Therapeutics 2000, 292:22-30.
25. Hoarau C., Martin L., Faugaret D., Baron C., Dauba A., Aubert-Jacquin C., Velge-Roussel F., Lebranchu Y. Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS ONE 2008, 3:e2753.
26. Hosoya T., Ogawa A., Sakai F., Kadooka Y. A cheese-containing diet modulates immune responses and alleviates dextran sodium sulfate-induced colitis in mice. Journal of Dairy Science 2012, 95:2810-2818.
27. Khosravi A., Yáñez A., Price J.G., Chow A., Merad M., Goodridge H.S., Mazmanian S.K. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host & Microbe 2014, 15:374-381.
28. Korhonen H. Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods 2009, 1:177-187.
29. Labonte M.E., Couture P., Richard C., Desroches S., Lamarche B. Impact of dairy products on biomarkers of inflammation: A systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. The American Journal of Clinical Nutrition 2013, 97:706-717.
30. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nature Reviews. Microbiology 2010, 8:171-184.
31. Leist M., Hartung T. Inflammatory findings on species extrapolations: Humans are definitely no 70-kg mice. Archives of Toxicology 2013, 87:563-567.
32. López P., Gueimonde M., Margolles A., Suárez A. Distinct Bifidobacterium strains drive different immune responses in vitro. International Journal of Food Microbiology 2010, 138:157-165.
33. Maccaferri S., Klinder A., Brigidi P., Cavina P., Costabile A. Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system. Applied and Environmental Microbiology 2012, 8:956-964.
34. Maconi G., Ardizzone S., Cucino C., Bezzio C., Russo A.G., Bianchi Porro G. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: A case-control study. World Journal of Gastroenterology 2010, 16:4297-4304.
35. Marteau P., Lepage P., Mangin I., Suau A., Doré J., Pochart P., Seksik P. Review article: Gut flora and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2004, 20:18-23.
36. Montbarbon M., Pichavant M., Langlois A., Erdual E., Maggiotto F., Neut C., Mallevaey T., Dharancy S., Dubuquoy L., Trottein F., Cortot A., Desreumaux P., Gosset P., Bertin B. Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment. PLoS ONE 2013, 8:e62208.
37. Monteagudo-Mera A., Rodríguez-Aparicio L., Rúa J., Martinez-Blanco H., Navasa N., García-Armesto M.R., Ferrero M.A. In vitro evaluation of physiological probiotic properties of different lactic acid bacteria strains of dairy and human origin. Journal of Functional Foods 2012, 4:531-541.
38. Mounier J., Gelsomino R., Goerges S., Vancanney M., Vandemeulebroecke K., Hoste B., Scherer S., Swings J., Fitzgerald G.F., Cogan T.M. Surface microflora of four smear-ripened cheeses. Applied and Environmental Microbiology 2005, 71:6489-6500.
39. Ng S.C., Bernstein C.N., Vatn M.H., Lakatos P.L., Loftus E.V., Tysk C., O'Morain C., Moum B., Colombel J.F. Geographical variability and environmental risk factors in inflammatory bowel disease. Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD). Gut 2013, 62:630-649.
40. Nova E., Wärnberg J., Gómez-Martínez S., Díaz L.E., Romeo J., Marcos A. Immunomodulatory effects of probiotics in different stages of life. The British Journal of Nutrition 2007, 1:S90-S95.
41. Peran L., Camuesco D., Comalada M., Nieto A., Concha A., Diaz-Ropero M.P., Olivares M., Xaus J., Zarzuelo A., Galvez J. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World Journal of Gastroenterology 2005, 11:5185-5192.
42. Petrof E.O., Claud E.C., Gloor G.B., Allen-Vercoe E. Microbial ecosystems therapeutics: A new paradigm in medicine?. Beneficial Microbes 2013, 4:53-65.
43. Philippe D., Favre L., Foata F., Adolfsson O., Perruisseau-Carrier G., Vidal K., Reuteler G., Dayer-Schneider J., Mueller C., Blum S. Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World Journal of Gastroenterology 2011, 17:459-469.
44. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
45. Rahman A., Gleinser M., Lanhers M.C., Riedel C.U., Foligné B., Hanse M., Yen F.T., Klouj A., Afzal M., Back A., Mangavel C., Cailliez-Grimal C., Revol-Junelles A.M., Borges F. Survival of the psychrotrophic bacterium Carnobacterium maltaromaticum LMA 28 in the mice gastrointestinal tract, adhesion and immune consideration to human cells. International Dairy Journal 2013, 34:93-99.
46. Rajasekaran A., Kalaivani M. Designer foods and their benefits: A review. Journal of Food Science and Technology 2013, 50:1-16.
47. Rajendran N., Kumar D. Role of diet in the management of inflammatory bowel disease. World Journal of Gastroenterology 2010, 16:1442-1448.
48. Riedel C.U., Foata F., Philippe D., Adolfsson O., Eikmanns B.J., Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World Journal of Gastroenterology 2006, 12:3729-3735.
49. Romanin D., Serradell M., González Maciel D., Lausada N., Garrote G.L., Rumbo M. Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir. International Journal of Food Microbiology 2010, 140:102-108.
50. Roselli M., Finamore A., Nuccitelli S., Carnevali P., Brigidi P., Vitali B., Nobili F., Rami R., Garaguso I., Mengheri E. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflammatory Bowel Diseases 2009, 15:1526-1536.
51. Seksik P., Dray X., Sokol H., Marteau P. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?. Molecular Nutrition and Food Research 2008, 52:906-912.
52. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Xu W., Richards D.R., McDonald-Smith G.P., Gao H., Hennessy L., Finnerty C.C., López C.M., Honari S., Moore E.E., Minei J.P., Cuschieri J., Bankey P.E., Johnson J.L., Sperry J., Nathens A.B., Billiar T.R., West M.A., Jeschke M.G., Klein M.B., Gamelli R.L., Gibran N.S., Brownstein B.H., Miller-Graziano C., Calvano S.E., Mason P.H., Cobb J.P., Rahme L.G., Lowry S.F., Maier R.V., Moldawer L.L., Herndon D.N., Davis R.W., Xiao W., Tompkins R.G. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:3507-3512.
53. Stanton C., Ross R.P., Fitzgerald G.F., Van Sinderen D. Fermented functional foods based on probiotics and their biogenic metabolites. Current Opinion in Biotechnology 2005, 16:198-203.
54. Timmerman H.M., Koning C.J., Mulder L., Rombouts F.M., Beynen A.C. Monostrain, multistrain and multispecies probiotics:-A comparison of functionality and efficacy. International Journal of Food Microbiology 2004, 96:219-233.
55. Timmerman H.M., Niers L.E., Ridwan B.U., Koning C.J., Mulder L., Akkermans L.M., Rombouts F.M., Rijkers G.T. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clinical Nutrition: Official Journal of the European Society of Parenteral and Enteral Nutrition 2007, 26:450-459.
56. Tripathi M.K., Giri S.K. Probiotic functional foods: Survival of probiotics during processing and storage. Journal of Functional Foods 2014, 9:225-241.
57. Ul Haq M.R., Kapila R., Saliganti V. Consumption of β-casomorphins-7/5 induce inflammatory immune response in mice gut through Th2 pathway. Journal of Functional Foods 2014, 8:150-160.
58. van Baarlen P., Wells J.M., Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends in Immunology 2013, 34:208-215.
59. Viladomiu M., Hontecillas R., Yuan L., Lu P., Bassaganya-Riera J. Nutritional protective mechanisms against gut inflammation. The Journal of Nutritional Biochemistry 2013, 24:929-939.
60. Wallace J.L., MacNaughton W.K., Morris G.P., Beck P.L. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989, 96:29-36.
61. Zvirbliene A., Kiudelis G., Zalinkevicius R., Kupcinskas L. Dietary characteristics of patients with inflammatory bowel diseases. Medicina (Kaunas, Lithuania) 2006, 42:895-899.